common.study.topics.clinical

Testing Experimental Medication

common.study.values.description

Preliminary Evaluation of [68Ga]CBP8 in Healthy Individuals, Lung Cancer, and Idiopathic Pulmonary Fibrosis Patients

The goal of this study is to investigate the safety of [68Ga]CBP8 and its efficacy to detect collagen deposition in pulmonary fibrosis.

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

Pharmaceutical medication involved common.study.methods.has-drugs-yes
Patients and healthy individuals accepted common.study.methods.is-healthy-no

Drug - [68Ga]CBP8

Up to 15 mCi of [68Ga]CBP8 will be administered to each subject.

Diagnostic Test - PET Imaging

All subjects will undergo PET imaging after administration of [68Ga]CBP8.

participant.views.study.view.additional

participant.views.study.view.scientific-title

Preliminary Evaluation of [68Ga]CBP8 in Healthy Individuals, Lung Cancer Patients Undergoing Radiation Therapy Prior to the Resection of Locally Advanced Tumors, and Idiopathic Pulmonary Fibrosis Patients

common.study.values.clinical-trial-id

NCT03535545

participant.views.study.view.id

9avX8d